MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-12-2025
Microbot Medical Operating Income 2011-2026 | MBOT
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Microbot Medical
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -9.86 M | -13.3 M | -11.4 M | -9.09 M | -7.24 M | -7.24 M | 5.27 M | -9.64 M | 915 K | -1.09 M | -28.1 M | -21.9 M | -28.1 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 5.27 M | -28.1 M | -10.8 M |
Quarterly Operating Income Microbot Medical
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.86 M | -3.72 M | -3.02 M | - | -3.3 M | -2.51 M | -2.38 M | - | -2.54 M | -2.32 M | -2.92 M | - | -3.47 M | -3.56 M | -3.18 M | - | -2.55 M | -2.48 M | -2.39 M | - | -2.42 M | -1.88 M | -2.16 M | - | -1.79 M | -1.54 M | -1.92 M | - | -1.75 M | -1.89 M | -1.52 M | - | -1.24 M | -1.26 M | -1.23 M | - | -645 K | 118 K | 285 K | - | -29.7 K | -9.27 M | -8.96 M | - | -6.38 M | -7.96 M | -6.84 M | - | -6.66 M | -6.22 M | -6.26 M | - | -5.08 M | -5.35 M | -5.33 M | - | -6.16 M | -7.09 M | -7.51 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 285 K | -9.27 M | -3.56 M |
Operating Income of other stocks in the Medical instruments industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Baxter International
BAX
|
14 M | $ 19.11 | -0.98 % | $ 9.75 B |  USA |
 |
Becton, Dickinson and Company
BDX
|
2.58 B | $ 194.07 | -0.8 % | $ 55.8 B | USA |
 |
Ekso Bionics Holdings
EKSO
|
-10.5 M | $ 8.64 | -18.34 % | $ 174 M | USA |
 |
Harvard Bioscience
HBIO
|
1.89 M | $ 0.67 | 1.66 % | $ 28.4 M | USA |
 |
Repro Med Systems
KRMD
|
-10.3 M | $ 5.81 | 2.11 % | $ 265 M | USA |
 |
OraSure Technologies
OSUR
|
-28.2 M | $ 2.42 | -2.02 % | $ 180 M | USA |
 |
Alcon
ALC
|
580 M | $ 78.81 | -0.64 % | $ 40.4 B |  Schweiz |
 |
AtriCure
ATRC
|
-40 M | $ 39.56 | -1.54 % | $ 1.86 B | USA |
 |
Atrion Corporation
ATRI
|
22.6 K | - | - | $ 810 M | USA |
 |
ICU Medical
ICUI
|
43 M | $ 142.67 | -1.36 % | $ 3.48 B | USA |
 |
electroCore
ECOR
|
-19.3 M | $ 4.49 | -3.55 % | $ 24.8 K | USA |
 |
iRhythm Technologies
IRTC
|
-116 M | $ 177.44 | -0.63 % | $ 5.54 B | USA |
 |
AngioDynamics
ANGO
|
-40 M | $ 12.84 | -1.23 % | $ 525 M | USA |
 |
Isoray
ISR
|
-90.9 M | - | 0.03 % | $ 108 M | USA |
 |
The Cooper Companies
COO
|
683 M | $ 81.96 | -0.62 % | $ 16.3 B | USA |
 |
Glaukos Corporation
GKOS
|
-129 M | $ 112.91 | -1.16 % | $ 5.47 B | USA |
 |
Stereotaxis
STXS
|
-21.8 M | $ 2.3 | -0.22 % | $ 186 M | USA |
 |
LeMaitre Vascular
LMAT
|
52.3 M | $ 81.1 | -2.3 % | $ 1.82 B | USA |
 |
Haemonetics Corporation
HAE
|
222 M | $ 80.15 | -1.02 % | $ 4.03 B | USA |
 |
InfuSystem Holdings
INFU
|
1.65 M | $ 8.97 | 0.67 % | $ 185 M | USA |
 |
Masimo Corporation
MASI
|
-267 M | $ 130.06 | -0.77 % | $ 6.93 B | USA |
 |
Merit Medical Systems
MMSI
|
156 M | $ 88.14 | -0.47 % | $ 5.13 B | USA |
 |
Intuitive Surgical
ISRG
|
2.35 B | $ 566.36 | -1.09 % | $ 201 B | USA |
 |
Utah Medical Products
UTMD
|
16.8 M | $ 55.96 | -0.57 % | $ 203 M | USA |
 |
Milestone Scientific
MLSS
|
-6.76 M | $ 0.27 | -0.22 % | $ 21.5 M | USA |
 |
Nephros
NEPH
|
-1.59 M | $ 4.88 | 3.39 % | $ 50.7 M | USA |
 |
NeuroMetrix
NURO
|
-8.78 M | - | 5.05 % | $ 9.02 M | USA |
 |
Envista Holdings Corporation
NVST
|
-1.04 B | $ 21.71 | -0.91 % | $ 3.74 B | USA |
 |
STERIS plc
STE
|
867 M | $ 253.52 | -0.76 % | $ 25 B | USA |
 |
Pro-Dex
PDEX
|
10.7 M | $ 38.48 | -0.3 % | $ 127 M | USA |
 |
Predictive Oncology
POAI
|
-10.9 M | - | - | $ 32.4 M | USA |
 |
Pulse Biosciences
PLSE
|
-43.6 M | $ 13.73 | 0.22 % | $ 660 M | USA |
 |
ResMed
RMD
|
1 B | $ 240.87 | -0.91 % | $ 35.2 B | USA |
 |
Repligen Corporation
RGEN
|
47.7 M | $ 163.86 | -1.64 % | $ 9.13 M | USA |
 |
DENTSPLY SIRONA
XRAY
|
-879 M | $ 11.43 | 0.35 % | $ 2.32 B | USA |
 |
BioLife Solutions
BLFS
|
-7.13 M | $ 24.18 | -1.95 % | $ 1.11 B | USA |
 |
Retractable Technologies
RVP
|
-21.1 M | $ 0.77 | -0.63 % | $ 23.1 M | USA |
 |
STAAR Surgical Company
STAA
|
-12.6 M | $ 23.09 | -0.52 % | $ 1.13 B | USA |
 |
Teleflex Incorporated
TFX
|
151 M | $ 122.04 | 0.35 % | $ 5.72 B | USA |
 |
West Pharmaceutical Services
WST
|
570 M | $ 275.14 | -0.62 % | $ 20.1 B | USA |